English-major of Using Grammarly for Thesis Writing at Seniors' Perceptions IUH
International Journal of AI in Language Education · 2025
DOI: 10.54855/ijaile.25224 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of AI in Language Education, 2025. Verfasst von Thi Thuy An Thai und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Research indicated that the application of artificial intelligence has raised the caliber of English theses in recent years. This study focused on understanding the perceptions of Grammarly in English-major seniors' thesis writing. 150 participants in the survey were English-major seniors at the Industrial University of Ho Chi Minh City, who were working on their theses. This study employed both quantitative and qualitative methods, analyzing data collected through online questionnaires and interviews. The findings of this study provided valuable insights into how AI-powered tools like Grammarly affect the writing process and quality of English theses in the perception of the students, which could help teachers better incorporate these technologies into their academic writing assistance programs.
Zitieren
APA
Thai, T. T. A., Nguyen, H. H. G., & Nguyen, N. C. (2025). English-major of Using Grammarly for Thesis Writing at Seniors' Perceptions IUH. International Journal of AI in Language Education. https://doi.org/10.54855/ijaile.25224
Vancouver
Thai TTA, Nguyen HHG, Nguyen NC. English-major of Using Grammarly for Thesis Writing at Seniors' Perceptions IUH. International Journal of AI in Language Education. 2025. doi:10.54855/ijaile.25224
BibTeX
@article{Thai2025,
author = {Thai, Thi Thuy An and Nguyen, Hoai Huong Giang and Nguyen, Ngoc Chau},
title = {English-major of Using Grammarly for Thesis Writing at Seniors' Perceptions IUH},
journal = {International Journal of AI in Language Education},
year = {2025},
doi = {10.54855/ijaile.25224}
}
EUVIMED